Blindness is one of the most feared health hazards in our present society; millions of Europeans are threatened by blinding untreatable eye diseases producing costs of several billion Euros. EVI aims at devising and implementing programs and projects for new therapeutic strategies for eye diseases that are difficult or impossible to be treated presently. Its approach will incorporate the most recent scientific developments of the postgenomic area.
The European Vision Institute should be of enormous strategic importance for the future and is targeted towards more immediate policy objectives of improving the competitiveness of European Research assembling the top institutes together with partners from industry and academia. EVI integrates, conducts and supports research that helps to prevent and treat eye diseases and other disorders of vision. This research leads to sight-saving treatments, reduces visual impairment and blindness, and improves the quality of life for people of all ages.
Basel Series of Special Interest Focus Groups (SIFG) - „New Technologies for Outcome Measures in Uveal Melanoma” In Collaboration with the European Ocular Oncology Group and the International Society of Ocular Oncology Read more
The European Group on Ethics in Science and New Technologies (EGE), an independent advisory body to the Commission, has today published its Opinion on the ethics of genome editing. The Opinion analyses ethical questions raised by the application of genome editing in humans, animals and plants, and... Read more
The pandemic has given scientists a more prominent voice in society. They need to use it to push for better health through equality. Read more
MedOne Surgical announced the FDA 510(k) clearance of its MicroDose Injector device for low volume ophthalmic injections into the subretinal space. The pneumatically driven syringe system allows the surgeon to utilize a pneumatic air source, such as a vitrectomy system, to deliver a low volume... Read more
The importance of publications won’t come as news to anyone who has been in academia for a while. Still, Rolfs’s comments underscore the importance of not just doing good science, but also ensuring you receive appropriate recognition for it—particularly when it comes to authorship. Read more
The "Gateway to European Vision Research" is a web-based portal service for the European vision research community and major stakeholders.
An award and public recognition by any measure is a sign of inimitability - an acknowledgment that peers and professionals alike agree that a certain person excels in what they do.
Read more about the European Vision Award and the Carl Zeiss Young Investigator Award.
Ophthalmic Research - The Journal for Translational and Clinical Research is official affiliated with the European Vision Institute